Robin Vernooij
@robinvernooij.bsky.social
Assistant professor #UMCUtrecht | Nephrology | Dialysis | Cardiovascular diseases | Applied data science | 🚴+🏃♂️
🚨 Looking through the same lens, yet seeing different pictures!
New publication in @ndt-era.bsky.social on eGFR measurement with different equations and its corresponding risk on mortality, kidney failure, and AKI. >250k patients from @umcutrecht.bsky.social.
academic.oup.com/ndt/article/...
New publication in @ndt-era.bsky.social on eGFR measurement with different equations and its corresponding risk on mortality, kidney failure, and AKI. >250k patients from @umcutrecht.bsky.social.
academic.oup.com/ndt/article/...
March 13, 2025 at 9:53 AM
🚨 Looking through the same lens, yet seeing different pictures!
New publication in @ndt-era.bsky.social on eGFR measurement with different equations and its corresponding risk on mortality, kidney failure, and AKI. >250k patients from @umcutrecht.bsky.social.
academic.oup.com/ndt/article/...
New publication in @ndt-era.bsky.social on eGFR measurement with different equations and its corresponding risk on mortality, kidney failure, and AKI. >250k patients from @umcutrecht.bsky.social.
academic.oup.com/ndt/article/...
High-dose HDF results in increased QALYs at higher costs compared to HD, mainly due to increased dialysis costs. Yet, probability of HDF being cost-effective, across different thresholds, is very high.
@kidneyint.bsky.social, @theisn.org @umcutrecht.bsky.social @nephjc.bsky.social
@kidneyint.bsky.social, @theisn.org @umcutrecht.bsky.social @nephjc.bsky.social
January 30, 2025 at 1:35 PM
High-dose HDF results in increased QALYs at higher costs compared to HD, mainly due to increased dialysis costs. Yet, probability of HDF being cost-effective, across different thresholds, is very high.
@kidneyint.bsky.social, @theisn.org @umcutrecht.bsky.social @nephjc.bsky.social
@kidneyint.bsky.social, @theisn.org @umcutrecht.bsky.social @nephjc.bsky.social